Current estimates of fungal disease incidence and mortality are imprecise. Population at risk
denominators were used to estimate annual incidence for 2019–21. Extensive literature …

Cancer poses a formidable challenge, necessitating improved treatment strategies. Metal-
based drugs and nanotechnology offer new hope in this battle. Versatile gold complexes …

Despite a gradual decline in smoking rates over time, exposure to secondhand smoke
(SHS) continues to cause harm to nonsmokers, who are disproportionately children and …

Studies in shift workers and model organisms link circadian disruption to breast cancer.
However, molecular circadian rhythms in noncancerous and cancerous human breast …

Background High body mass index (BMI) is a major risk factor for cancer development, but
its impact on the global burden of cancer remains unclear. Methods We estimated global …

Abstract N6-methyladenosine (m6A) RNA modification is the most common and conserved
epigenetic modification in mRNA and has been shown to play important roles in cancer …

Nanomaterials as artificial enzymes (nanozymes) have aroused extensive research interest
owing to their highly stable, long storage period, and low-cost alternatives to enzymes …

Patients can be immunocompromised from a diverse range of disease and treatment factors,
including malignancies, autoimmune disorders and their treatments, and organ and stem …

Globally women face inequality in cancer outcomes; for example, smaller improvements in
life expectancy due to decreased cancer‐related deaths than men (0.5 vs 0.8 years, 1981 …

Background Multidisciplinary cancer conferences consist of regular meetings between
diverse specialists working together to share clinical decision making in cancer care. The …